Pay in 4 interest-free payments of $5.09 Learn more
Ships within 48 hours · Estimated delivery Aug 14 - Aug 19
Key Features Innovative metabolic therapy API High purity peptide manufacturing Suitable for pharmaceutical research and formulation Applications Obesity management research Metabolic disease therapeutics Next-generation peptide drug development Available Form Lyophilized peptide powder Dapagliflozin API Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor used in the management of Type-2 Diabetes, heart failure, and chronic kidney disease
Pharmacy verification : Pharmacists should counsel patients on proper use and verify understanding before dispensing
Ann Intern Med (2015) 162(5):33544
Similar to otherwise healthy older adults, individuals living with chronic health conditions stand to greatly benefit from participation in RT
US$ 26.24
US$ 26.99
US$ 21.90
US$ 20.18
